Component

Apo-10-prime-lycopenoic acid

Apo-10-prime-lycopenoic acid. Species, exposure and limitations are retained in each linked claim.

14 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Apo-10-prime-lycopenoic acid did not inhibit differentiation of 3T3-L1 adipocytes.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"}
    experimental_model
    Adipocyte transcription and adipose-tissue experiments
    exposure
    Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid
    limitations
    Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Mouse 3T3-L1 cells and in-vivo adipose model
    plain_language
    Retinoid-related signaling did not mean identical effects to retinoic acid.
    primary_references
    [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
    tissue_or_cell_type
    Adipocyte differentiation and inflammatory gene expression

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 936–947

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Adipocyte transcription and adipose-tissue experiments · source_derived_draft · unverified_draft

    ### lycopene-apo-adipogenesis-null Apo-10-prime-lycopenoic acid did not inhibit differentiation of 3T3-L1 adipocytes. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Retinoid-related signaling did not mean identical effects to retinoic acid. organism: Mouse 3T3-L1 cells and in-vivo adipose model tissue_or_cell_type: Adipocyte differentiation and inflammatory gene expression experimental_model: Adipocyte transcription and adipose-tissue experiments limitations: Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified. exposure: Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid evidence_span: {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"} [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
    Complete structured claim and evidence
  2. The metabolite prevented increases in IL-6 and IL-1-beta in the studied adipose inflammation models.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"}
    experimental_model
    Adipocyte transcription and adipose-tissue experiments
    exposure
    Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid
    limitations
    Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Mouse 3T3-L1 cells and in-vivo adipose model
    plain_language
    The tested product changed inflammatory responses in preclinical systems.
    primary_references
    [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
    tissue_or_cell_type
    Adipocyte differentiation and inflammatory gene expression

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 949–960

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Adipocyte transcription and adipose-tissue experiments · source_derived_draft · unverified_draft

    ### lycopene-apo-adipose-cytokines The metabolite prevented increases in IL-6 and IL-1-beta in the studied adipose inflammation models. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The tested product changed inflammatory responses in preclinical systems. organism: Mouse 3T3-L1 cells and in-vivo adipose model tissue_or_cell_type: Adipocyte differentiation and inflammatory gene expression experimental_model: Adipocyte transcription and adipose-tissue experiments limitations: Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified. exposure: Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid evidence_span: {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"} [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
    Complete structured claim and evidence
  3. The metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
    experimental_model
    Cell-cycle assays and NNK-induced mouse tumor model
    exposure
    Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
    limitations
    Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human bronchial cell lines; A/J mice separately specified
    plain_language
    A cell-cycle accelerator decreased.
    primary_references
    [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    tissue_or_cell_type
    Bronchial epithelium and lung tumors

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 715–726

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft

    ### lycopene-apo-cyclin The metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A cell-cycle accelerator decreased. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    Complete structured claim and evidence
  4. Apo-10-prime-lycopenoic acid induced glutamate-cysteine ligases in the bronchial-cell experiment.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    The response included machinery used to make glutathione.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 533–544

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-gcl Apo-10-prime-lycopenoic acid induced glutamate-cysteine ligases in the bronchial-cell experiment. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response included machinery used to make glutathione. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  5. The metabolite increased total intracellular glutathione in BEAS-2B cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    A measured glutathione pool rose; this does not show that dietary precursors were sufficient in every tissue.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 559–570

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-glutathione The metabolite increased total intracellular glutathione in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A measured glutathione pool rose; this does not show that dietary precursors were sufficient in every tissue. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  6. Apo-10-prime-lycopenoic acid induced glutathione S-transferases in BEAS-2B cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    Some responding enzymes use glutathione in conjugation reactions.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 546–557

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-gst Apo-10-prime-lycopenoic acid induced glutathione S-transferases in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some responding enzymes use glutathione in conjugation reactions. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  7. Apo-10-prime-lycopenoic acid induced heme oxygenase-1 in bronchial epithelial cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    One responding enzyme handles heme turnover.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 507–518

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-hmox1 Apo-10-prime-lycopenoic acid induced heme oxygenase-1 in bronchial epithelial cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: One responding enzyme handles heme turnover. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  8. Mean tumors per mouse fell from 16 with NNK alone to 10, 7 and 5 across ascending metabolite diet doses.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
    experimental_model
    Cell-cycle assays and NNK-induced mouse tumor model
    exposure
    Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
    limitations
    Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    A/J mouse
    plain_language
    The animal result is a research lead, not demonstrated human cancer prevention.
    primary_references
    [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    tissue_or_cell_type
    Bronchial epithelium and lung tumors

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 754–765

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft

    ### lycopene-apo-mouse-tumors Mean tumors per mouse fell from 16 with NNK alone to 10, 7 and 5 across ascending metabolite diet doses. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The animal result is a research lead, not demonstrated human cancer prevention. organism: A/J mouse tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    Complete structured claim and evidence
  9. Apo-10-prime-lycopenoic acid induced NQO1 in BEAS-2B cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    This shares a protective enzyme node with other compounds already in the ledger.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 520–531

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-nqo1 Apo-10-prime-lycopenoic acid induced NQO1 in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: This shares a protective enzyme node with other compounds already in the ledger. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  10. Apo-10-prime-lycopenoic acid increased nuclear Nrf2 accumulation in BEAS-2B cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    A defined breakdown product activated the Nrf2-associated response.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 494–505

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-nrf2 Apo-10-prime-lycopenoic acid increased nuclear Nrf2 accumulation in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A defined breakdown product activated the Nrf2-associated response. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  11. The metabolite suppressed endogenous ROS generation and hydrogen-peroxide-induced injury in BEAS-2B cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
    experimental_model
    Metabolite exposure and gene/protein/redox measurements
    exposure
    Time- and dose-dependent apo-10-prime-lycopenoid exposure
    limitations
    Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human BEAS-2B bronchial epithelial cells
    plain_language
    Cells were less vulnerable to the tested oxidant exposure.
    primary_references
    [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    tissue_or_cell_type
    Nucleus, antioxidant enzymes and intracellular glutathione

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 572–583

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft

    ### lycopene-apo-oxidant-injury The metabolite suppressed endogenous ROS generation and hydrogen-peroxide-induced injury in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Cells were less vulnerable to the tested oxidant exposure. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
    Complete structured claim and evidence
  12. The metabolite increased p21 and p27 protein in the tested bronchial cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
    experimental_model
    Cell-cycle assays and NNK-induced mouse tumor model
    exposure
    Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
    limitations
    Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human bronchial cell lines; A/J mice separately specified
    plain_language
    Proteins that restrain cell-cycle progression increased.
    primary_references
    [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    tissue_or_cell_type
    Bronchial epithelium and lung tumors

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 728–739

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft

    ### lycopene-apo-p21-p27 The metabolite increased p21 and p27 protein in the tested bronchial cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Proteins that restrain cell-cycle progression increased. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    Complete structured claim and evidence
  13. Apo-10-prime-lycopenoic acid activated the RAR-beta promoter and increased RAR-beta expression.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
    experimental_model
    Cell-cycle assays and NNK-induced mouse tumor model
    exposure
    Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
    limitations
    Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Human bronchial cell lines; A/J mice separately specified
    plain_language
    A lycopene product can intersect retinoid signaling without becoming vitamin A.
    primary_references
    [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    tissue_or_cell_type
    Bronchial epithelium and lung tumors

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 741–752

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft

    ### lycopene-apo-rarb Apo-10-prime-lycopenoic acid activated the RAR-beta promoter and increased RAR-beta expression. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A lycopene product can intersect retinoid signaling without becoming vitamin A. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
    Complete structured claim and evidence

What acts on it

  1. NAD+ supported conversion of apo-10-prime-lycopenal to apo-10-prime-lycopenoic acid in ferret hepatic fractions.

    NAD+ → Apo-10-prime-lycopenoic acid source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"}
    experimental_model
    Recombinant ferret enzyme and tissue-fraction metabolism
    exposure
    5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH
    limitations
    Ferret experiments do not quantify human cleavage flux or predict supplement response.
    nutrient_topic
    Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
    organism
    Ferret
    plain_language
    The oxidized niacin-derived cofactor helped steer the aldehyde toward an acid.
    primary_references
    [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
    tissue_or_cell_type
    BCO2 enzyme; hepatic fractions and lung

    Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 338–349

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant ferret enzyme and tissue-fraction metabolism · source_derived_draft · unverified_draft

    ### lycopene-apo-nad NAD+ supported conversion of apo-10-prime-lycopenal to apo-10-prime-lycopenoic acid in ferret hepatic fractions. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The oxidized niacin-derived cofactor helped steer the aldehyde toward an acid. organism: Ferret tissue_or_cell_type: BCO2 enzyme; hepatic fractions and lung experimental_model: Recombinant ferret enzyme and tissue-fraction metabolism limitations: Ferret experiments do not quantify human cleavage flux or predict supplement response. exposure: 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH evidence_span: {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"} [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards